Formate-dependent Regulation of Cancer Metastasis
This project aims to elucidate the role of formate overflow in cancer metastasis and develop targeted therapies by investigating mitochondrial one-carbon metabolism and its signaling mechanisms.
Projectdetails
Introduction
Mechanisms underlying cancer metastasis are poorly understood and context dependent. An essential feature of disseminating cancer cells is metabolic plasticity, which allows cellular adaptation to changing environmental conditions along the metastatic cascade.
Discovery of Formate Overflow
I discovered in 2016 the phenomenon of formate overflow, an alternative pathway for serine catabolism via folate-mediated one-carbon (1C) cycle. Instead of using formate for nucleotide synthesis (to support proliferation), formate overflow is characterized by formate excretion from cancer cells.
Impact on Cancer Metastasis
Furthermore, I have convincingly demonstrated that mitochondrial 1C metabolism and increased extracellular formate concentrations promote cancer metastasis in a growth-independent manner. However, it remains unknown which intermediates of 1C metabolism contribute to this phenotype, how formate controls metastasis, and how it can be targeted therapeutically.
Research Objectives
To cross the current edge of knowledge, I will:
- Take advantage of genetic and newly developed analytical methods to dissect how the formate-dependent effects are propagated in cells.
- Describe intrinsic mechanisms to explain how the formate signal is relayed to promote metastasis.
- Exploit formate overflow for cancer cell killing by directly targeting the formate molecule.
Novel Concept and Tool Development
4M8 will explain a novel concept of how a mitochondrial metabolic signal drives cancer cells towards a pro-metastatic phenotype and how this knowledge can be translated into a signature to analyze the metabolic state in human tumor samples.
Finally, we will develop a novel tool to target formate directly within cancer cells.
Conclusion
In sum, our research will shed light on an unexplored field of cancer metabolism, providing the foundation to develop novel treatment approaches against metastatic cancer, the primary cause of cancer death.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-5-2024 |
Einddatum | 30-4-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- LUXEMBOURG INSTITUTE OF HEALTHpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting the Metabolic Dependencies of Metastatic Tumor CellsThis project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes. | ERC Starting... | € 1.493.750 | 2024 | Details |
Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic CancerPalmitoMET seeks to discover inhibitors of specific protein lipidation to combat cancer metastasis, aiming to develop first-in-class drugs for preclinical and clinical applications. | ERC Proof of... | € 150.000 | 2023 | Details |
Functional characterization of the colorectal cancer metastasis microbiomeThe METABAC project aims to investigate the functional roles of bacteria in colorectal cancer metastasis using innovative platforms to uncover their impact on cancer progression and potential therapeutic targets. | ERC Starting... | € 1.499.894 | 2024 | Details |
The role of Palmitoylation ERASERs in cancer metastasisThis project aims to uncover the role of palmitoylation erasers in promoting breast cancer metastasis, using multi-omics and in vivo models to develop targeted therapies based on dietary influences. | ERC Starting... | € 1.495.519 | 2024 | Details |
Intercellular trading in nucleotide metabolism: an emerging targetThis project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors. | ERC Starting... | € 1.450.000 | 2022 | Details |
Targeting the Metabolic Dependencies of Metastatic Tumor Cells
This project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes.
Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic Cancer
PalmitoMET seeks to discover inhibitors of specific protein lipidation to combat cancer metastasis, aiming to develop first-in-class drugs for preclinical and clinical applications.
Functional characterization of the colorectal cancer metastasis microbiome
The METABAC project aims to investigate the functional roles of bacteria in colorectal cancer metastasis using innovative platforms to uncover their impact on cancer progression and potential therapeutic targets.
The role of Palmitoylation ERASERs in cancer metastasis
This project aims to uncover the role of palmitoylation erasers in promoting breast cancer metastasis, using multi-omics and in vivo models to develop targeted therapies based on dietary influences.
Intercellular trading in nucleotide metabolism: an emerging target
This project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis. | EIC Pathfinder | € 2.591.050 | 2023 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis
3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.